KUSTOM ENTERTAINMENT, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that KUSTOM ENTERTAINMENT, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $14.58M | Apr 13, 2018 |
| FY2017 | Dec 31, 2016 | $16.57M | Apr 13, 2018 |
| FY2016 | Dec 31, 2015 | $20.03M | Mar 28, 2017 |
| FY2015 | Dec 31, 2014 | $17.44M | Mar 7, 2016 |
| FY2014 | Dec 31, 2013 | $17.83M | Mar 23, 2015 |
| FY2013 | Dec 31, 2012 | $17.62M | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | $19.58M | Mar 27, 2013 |
| FY2011 | Dec 31, 2010 | $25.21M | Mar 28, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.75M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $13.52M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $28.25M | May 2, 2025 |
| FY2023 | Dec 31, 2022 | $37.01M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $21.41M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $10.51M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $10.44M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $11.29M | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | $14.58M | Mar 29, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.35M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $3.12M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $5.76M | May 2, 2025 |
| FY2023 | Dec 31, 2022 | $2.32M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $5.66M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $4.06M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $3.23M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.96M | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | $4.54M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $5.30M | Apr 13, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.67M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($19.84M) | Apr 13, 2026 |
| FY2024 | Sep 30, 2024 | $35.00M | May 2, 2025 |
| FY2022 | Dec 31, 2022 | ($18.87M) | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $25.53M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($2.63M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($10.01M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($15.54M) | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | ($12.25M) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($12.71M) | Apr 13, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.88M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($11.38M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($22.24M) | May 2, 2025 |
| FY2023 | Dec 31, 2022 | ($29.73M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($14.76M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($7.66M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($6.03M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($10.56M) | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | ($11.20M) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($12.49M) | Apr 13, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $551.4K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.34M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $2.62M | May 2, 2025 |
| FY2023 | Dec 31, 2022 | $2.29M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.93M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.84M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $2.01M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.44M | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | $3.15M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $3.19M | Apr 13, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.23M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $14.51M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $28.00M | May 2, 2025 |
| FY2023 | Dec 31, 2022 | $32.06M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $20.42M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $11.73M | Apr 15, 2022 |
| FY2019 | Dec 31, 2019 | $9.27M | Apr 6, 2020 |
| FY2019 | Dec 31, 2018 | $14.52M | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | $15.74M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $17.79M | Apr 13, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($5.11M) | May 2, 2025 |
| FY2024 | Dec 31, 2023 | ($9.89M) | May 2, 2025 |
| FY2023 | Dec 31, 2022 | ($18.58M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($17.83M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($13.27M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($1.12M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($9.01M) | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | ($6.35M) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($5.90M) | Apr 13, 2018 |
| FY2016 | Dec 31, 2015 | ($7.69M) | Mar 28, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $258.1K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $28.8K | Apr 13, 2026 |
| FY2022 | Dec 31, 2022 | $2.07M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $6.43M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $621.9K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $204.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $42.5K | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | $322.7K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $340.7K | Apr 13, 2018 |
| FY2016 | Dec 31, 2015 | $423.1K | Mar 28, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.33M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $27.74M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $47.03M | May 2, 2025 |
| FY2023 | Dec 31, 2022 | $56.67M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $82.99M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $20.80M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $8.92M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $14.34M | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | $13.17M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $18.84M | Apr 13, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.96M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $36.75M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $35.58M | May 2, 2025 |
| FY2023 | Dec 31, 2022 | $20.33M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $27.13M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.44M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $15.23M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $15.75M | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | $12.31M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $11.08M | Apr 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $14.36M | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | ($6.32M) | Mar 31, 2021 |
| FY2020 | Dec 31, 2018 | ($1.41M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $863.7K | Apr 6, 2020 |
| FY2018 | Dec 31, 2016 | $7.76M | Mar 29, 2019 |
| FY2017 | Dec 31, 2015 | $18.76M | Apr 13, 2018 |
| FY2016 | Dec 31, 2014 | $6.26M | Mar 28, 2017 |
| FY2015 | Dec 31, 2013 | $7.05M | Mar 7, 2016 |
| FY2014 | Dec 31, 2012 | $7.90M | Mar 23, 2015 |
| FY2013 | Dec 31, 2011 | $9.31M | Mar 27, 2014 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jun 30, 2022 | $667.9K | Mar 31, 2023 |
| FY2022 | Jun 30, 2021 | $1.13M | Mar 31, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($144.18M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($137.51M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($117.67M) | May 2, 2025 |
| FY2023 | Dec 31, 2022 | ($91.98M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($68.67M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($90.01M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($87.39M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($77.38M) | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | ($61.91M) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($49.66M) | Apr 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $757.4K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $219.3K | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $680.5K | May 2, 2025 |
| FY2023 | Dec 31, 2022 | $3.53M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $32.01M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $4.36M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $359.7K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.60M | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | $54.7K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $3.88M | Apr 13, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $845.4K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.10M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $6.11M | May 2, 2025 |
| FY2023 | Dec 31, 2022 | $927.8K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.12M | Mar 31, 2023 |
| FY2020 | Dec 31, 2020 | $148.3K | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | $6.50M | Mar 31, 2021 |
| FY2014 | Dec 31, 2013 | $2.31M | Mar 23, 2015 |
| FY2013 | Dec 31, 2012 | $2.40M | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | $2.36M | Mar 27, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (17) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | (33,488) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | (9) | May 2, 2025 |
| FY2023 | Dec 31, 2022 | (8) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 10 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | (1) | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | (1) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | (2) | Apr 13, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (17) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | (33,488) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | (9) | May 2, 2025 |
| FY2023 | Dec 31, 2022 | (8) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 10 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | (1) | Apr 6, 2020 |
| FY2018 | Dec 31, 2017 | (1) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | (2) | Apr 13, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2012 | 2.10M | Mar 27, 2014 |
| FY2013 | Aug 24, 2012 | 16.79M | Mar 27, 2014 |